Institut Merieux
🏢 View company profile →34Patents
0Active
34Granted
38Portfolio score
Filing activity: Jul 3, 1973 → Jun 21, 1989
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4931546A | Process for the treatment of collagen, notably for facilitating its cross-linking, and the collagen obtained by the application of the said process | Human Necessities | 117 | Expired |
| US4859587A | Recombinant herpes simplex viruses, vaccines and methods | Chemistry; Metallurgy | 62 | Expired |
| US4308254A | Material able to fix reversibly biologial macromolecules, its preparation and its application | Performing Operations; Transporting | 46 | Expired |
| US4675384A | Fractionation/purification of plasma by ion exchange chromatography | Human Necessities | 46 | Expired |
| US4673734A | Porous mineral support coated with an aminated polysaccharide polymer | Emerging Cross-Sectional Technologies | 45 | Expired |
| US4453926A | Scarifier | Human Necessities | 39 | Expired |
| US5118794A | Process for stabilizing human albumin solutions and the solution obtained | Human Necessities | 38 | Expired |
| US4719107A | Immunomodulating medication based on Fc fragments of human IgG | Emerging Cross-Sectional Technologies | 37 | Expired |
| US3992367A | Process for the preparation of purified albumin by thermocoagulation and albumin obtained by said process | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4554159A | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) | Chemistry; Metallurgy | 28 | Expired |
| US4689225A | Vaccine for cytomegalovirus | Emerging Cross-Sectional Technologies | 24 | Expired |
| US4148885A | Immunostimulant medicine | Human Necessities | 19 | Expired |
| US5110909A | Macromolecular conjugates of hemoglobin, a procedure for their preparation and their uses | Human Necessities | 18 | Expired |
| US4182751A | New immunostimulant medicament and process of preparing same | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5075110A | Stabilizing vaccines | Chemistry; Metallurgy | 13 | Expired |
| US4764279A | Process for preparing the principal proteins of hemolyzed blood in the non-denatured form | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4214592A | Patch for skin tests | Human Necessities | 12 | Expired |
| US4965205A | Culture medium for bacteria of the bordetella genus containing etherified derivative of D-glucose and a cyclodextrin | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4542016A | Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use | Chemistry; Metallurgy | 11 | Expired |
| US4087519A | Medicament for the treatment of hepatitis and/or acute or chronic infections due to the virus of hepatitis B | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4242270A | Process for separating lipids from endotoxins | Human Necessities | 8 | Expired |
| US4774086A | Process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the Bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine | Emerging Cross-Sectional Technologies | 8 | Expired |
| USD297052S | Skin micropuncture implement | General | 8 | Expired |
| US4303638A | Cholera vaccine | Human Necessities | 7 | Expired |
| US4337243A | Immunostimulant medicament and process of preparing same | Emerging Cross-Sectional Technologies | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.